锦华新材：精细化工基石稳固，电子化学品崭露头角-20260203

Investment Rating - The report assigns a "Buy" rating for the company, marking the first coverage of the stock [1]. Core Insights - The company, Zhejiang Jinhua New Materials Co., Ltd., is a leading supplier of ketoxime products and has established a strong position in the fine chemical industry, particularly in silane crosslinking agents and hydroxylamine salts [9][14]. - The hydroxylamine salt market is expanding, driven by increased demand in downstream industries such as agriculture, pharmaceuticals, and electronics, which opens up long-term growth opportunities for the company [9][40]. - The company has a robust technical innovation capability and a rich customer base, including partnerships with major international and domestic chemical companies [9][57]. Summary by Sections 1. Company Overview - Zhejiang Jinhua New Materials specializes in the R&D, production, and sales of ketoxime series fine chemicals, including silane crosslinking agents and hydroxylamine salts [9][14]. - The company has received numerous accolades, including being recognized as a national "little giant" enterprise and a high-tech enterprise [14]. 2. Market Dynamics - The fine chemical industry is a strategic focus in China's chemical sector, with hydroxylamine salts being a key raw material for various applications, including low-toxicity pesticides and high-efficiency metal extractants [40][39]. - The global hydroxylamine salt market is projected to grow from 2.714 billion yuan in 2023 to 3.179 billion yuan by 2028, with a CAGR of 3.21% [40][41]. 3. Technical Innovation and Customer Base - The company has established a green circular industrial chain for ketoxime products, showcasing its commitment to sustainable practices and innovation [16][57]. - Jinhua New Materials has built a strong customer network, including partnerships with Bayer and domestic leaders like Wanhua Chemical, ensuring a stable demand for its products [60][57]. 4. Financial Projections - The company is expected to achieve revenues of 1.064 billion yuan in 2025, with a projected net profit of 198.77 million yuan, reflecting a growth trajectory despite a slight decline in 2025 [1][21]. - The earnings per share (EPS) are forecasted to be 1.47 yuan in 2025, with a P/E ratio of 34.00, indicating a favorable valuation compared to peers [1][21].